A Case of Mental Change in a Patient Who Received a Zoletil Injection
Journal of The Korean Society of Clinical Toxicology
; : 23-27, 2013.
Article
in Ko
| WPRIM
| ID: wpr-212415
Responsible library:
WPRO
ABSTRACT
Zoletil is a non-opioid, non-barbiturate animal anesthetic and proprietary combination of two drugs, a dissociative anesthetic drug, tiletamine, with the benzodiazepine anxiolytic drug, zolazepam. Zoletil has greater potency than ketamine. Zoletil is abused for recreational purposes, especially by people with easy access to medicine. However, in Korea, it is available over-the-counter. Here we report on a case of an 83-year-old woman who received injection of seven vials of "Zoletil 50" by her daughter and presented with an altered mental change. Her mental state was stupor and vital sign was hypotension, bradycardia. Her blood tests indicated metabolic and respiratory acidosis and hyperkalemia. She was treated with intravenous naloxone and flumazenil but was not responsive. She was admitted to the ICU and treated with supportive therapy. Her mental state showed transient recovery, however, her clinical manifestation worsened and she expired.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Tiletamine
/
Acidosis, Respiratory
/
Zolazepam
/
Benzodiazepines
/
Bradycardia
/
Nuclear Family
/
Flumazenil
/
Drug Combinations
/
Stupor
/
Vital Signs
Limits:
Aged80
/
Animals
/
Female
/
Humans
Country/Region as subject:
Asia
Language:
Ko
Journal:
Journal of The Korean Society of Clinical Toxicology
Year:
2013
Type:
Article